Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003236 · ClinicalTrials.gov registry record · Phase 2
Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer
A Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003236 is a Phase 2 study that has completed, run by Eastern Cooperative Oncology Group.
The verdict
NCT00003236, a Phase 2 study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of ISIS 5132 with ISIS 3521 in treating women who have metastatic breast cancer that has not responded to previous therapy.
Interventions
- BIOLOGICAL ISIS 3521
- DRUG ISIS 5132
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-07-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003236
The ClinicalTrials.gov registry entry for NCT00003236 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ISIS 3521 is the first listed.
NCT00003236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003236 about?
NCT00003236 is a clinical study titled "Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of ISIS 5132 with ISIS 3521 in treating women who have metastatic breast cancer that has not responded to previous ...
What is the current status of trial NCT00003236?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-07-13.
What interventions are being tested in trial NCT00003236?
The interventions under investigation include: ISIS 3521 (BIOLOGICAL), ISIS 5132 (DRUG).
Who is sponsoring clinical trial NCT00003236?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.